The United Laboratories International Holdings Limited

中/EN
中文繁體 English
  • Investor Relations
    IR Home Corporate Overview Financial Highlights Financial Reports ESG Reports Regulatory Filings Press Releases Company Presentations Stock Quotes & Charts Analyst Coverage FAQs IR Contact
  • Corporate
Investor Relations
  • IR Home
  • Corporate Overview
  • Financial Highlights
  • Financial Reports
  • ESG Reports
  • Regulatory Filings
  • Press Releases
  • Company
    Presentations
  • Stock Quotes &
    Charts
  • Analyst Coverage
  • FAQs
  • IR Contact

Press Releases

2007
Please select
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
NOV
04
TUL Granted an EU Certificate of Suitability; Products Acquired International Standard Accreditation
SEP
23
The United Laboratories International Holdings Limited Announces 2007 Interim Results
JUN
15
TUL Recorded a Solid Trading Debut - Share Price Gained 31.27% to Close at HK$3.61
JUN
13
TUL Announces Results of Share Offer - Public Offer Received 26.87 Times Over-subscription, Final Offer Price Set at Top-end HK$2.75 Per Share
JUN
03
TUL Announces Initial Public Offering - Raise HK$675 Million to HK$825 Million for Business Expansion to Capture the Future Growth of Pharmaceutical Industry in China
Disclaimer | Sitemap

Copyright © 2019 The United Laboratories International Holdings Limited. All rights reserved.